Journal of Hematology and Oncology

SJR Rank #67H-index: 194SJR: 11.824Best quartile: Q1Open AccessAPC: US$4,990Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

BioMed Central Ltd

Country

United Kingdom

Type

journal

SJR by Edition

20222025036912

Subject Categories

  • Cancer ResearchQ1
  • HematologyQ1
  • Molecular BiologyQ1
  • OncologyQ1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

CAR-T cell therapy researchAcute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionMultiple Myeloma Research and TreatmentsAcute Lymphoblastic Leukemia researchImmunotherapy and Immune ResponsesChronic Myeloid Leukemia TreatmentsHematopoietic Stem Cell Transplantation

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

2022202504590135180

Detailed Information

ISSN

1756-8722

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

28.48

References per Document

121.56

Coverage

2008-2026

Scope

Journal of Hematology & Oncology is an open access journal that publishes top-quality research encompassing all aspects of hematology and oncology. The journal also publishes reviews and research highlights on "hot topics" from leading experts in the field. Hematology and oncology are closely intertwined and rapidly evolving fields. More physician scientists performing laboratory-based research are rapidly bringing research in hematology and oncology from bench to bedside. Journal of Hematology & Oncology aims to meet the demand for a journal dedicated to publishing discovery from both of these fields.

Metrics from SCImago Journal Rank 2025. View on SCImago